|
AU2016204462A1
|
|
Nicked or gapped nucleic acid molecules and uses thereof
|
|
AU2015202154A1
|
|
Lipopeptides for delivery of nucleic acids
|
|
AU2014262213A1
|
|
Amino acid lipids and uses thereof
|
|
AU2014202674A1
|
|
Amino acid lipids and uses thereof
|
|
AU2014200144A1
|
|
Nicked or gapped nucleic acid molecules and uses thereof
|
|
US2014178462A1
|
|
Amphoteric liposomes comprising neutral lipids
|
|
AU2013209381A1
|
|
Compounds and methods for peptide ribonucleic acid condensate particles for RNA therapeutics
|
|
SG11201401314PA
|
|
Synthesis and uses of nucleic acid compounds with conformationally restricted monomers
|
|
WO2011139710A1
|
|
Nucleic acid compounds with conformationally restricted monomers and uses thereof
|
|
WO2011120023A1
|
|
Nucleic acid compounds for inhibiting survivin gene expression uses thereof
|
|
AU2010315124A1
|
|
Activity generating delivery molecules
|
|
CN102481256A
|
|
Amphoteric liposomes comprising imino lipids
|
|
CN102317457A
|
|
E. coli mediated gene silencing of beta-catenin
|
|
IL201785D0
|
|
Compounds and compositions of amino acid lipids and uses thereof
|
|
EP2349210A2
|
|
Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics
|
|
EP2361305A2
|
|
Nucleic acid compounds for inhibiting birc5 gene expression and uses thereof
|
|
CA2733204A1
|
|
Nucleic acid compounds for inhibiting plk1 gene expression and uses thereof
|
|
EP2277508A1
|
|
Emulation of lipoprotein structures
|
|
EP2494993A2
|
|
Amino acid lipids and uses thereof
|
|
EP2462924A2
|
|
Improvements in or relating to amphoteric liposomes.
|
